ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 163 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,078 | -1.7% | 301,852 | +0.2% | 0.08% | -9.8% |
| Q3 2021 | $1,097 | -16.5% | 301,297 | 0.0% | 0.09% | -11.5% |
| Q2 2021 | $1,314 | +6.1% | 301,297 | 0.0% | 0.10% | -2.8% |
| Q1 2021 | $1,238 | +3.0% | 301,297 | 0.0% | 0.11% | -7.0% |
| Q4 2020 | $1,202 | +56.9% | 301,297 | +6.2% | 0.12% | +43.8% |
| Q3 2020 | $766 | -1.8% | 283,797 | 0.0% | 0.08% | -10.1% |
| Q2 2020 | $780 | +16.4% | 283,797 | 0.0% | 0.09% | -2.2% |
| Q1 2020 | $670 | -49.7% | 283,797 | +0.2% | 0.09% | -32.6% |
| Q4 2019 | $1,331 | +39.1% | 283,097 | -1.0% | 0.14% | +35.0% |
| Q3 2019 | $957 | +1.7% | 286,097 | 0.0% | 0.10% | +2.0% |
| Q2 2019 | $941 | +7.7% | 286,097 | -0.9% | 0.10% | +5.4% |
| Q1 2019 | $874 | +10.8% | 288,597 | -0.5% | 0.09% | -6.1% |
| Q4 2018 | $789 | -19.5% | 290,097 | -0.5% | 0.10% | -8.3% |
| Q3 2018 | $980 | +30.3% | 291,597 | 0.0% | 0.11% | +25.6% |
| Q2 2018 | $752 | +17.1% | 291,597 | 0.0% | 0.09% | +22.9% |
| Q1 2018 | $642 | +10.7% | 291,597 | 0.0% | 0.07% | +29.6% |
| Q4 2017 | $580 | -49.1% | 291,597 | -17.1% | 0.05% | -44.9% |
| Q3 2017 | $1,139 | +0.6% | 351,685 | 0.0% | 0.10% | -2.0% |
| Q2 2017 | $1,132 | +24.0% | 351,685 | +9.4% | 0.10% | +25.0% |
| Q1 2017 | $913 | +21.9% | 321,535 | 0.0% | 0.08% | +23.1% |
| Q4 2016 | $749 | +38.7% | 321,535 | 0.0% | 0.06% | +38.3% |
| Q3 2016 | $540 | +59.8% | 321,535 | 0.0% | 0.05% | +67.9% |
| Q2 2016 | $338 | +20.7% | 321,535 | 0.0% | 0.03% | +16.7% |
| Q1 2016 | $280 | -28.0% | 321,535 | 0.0% | 0.02% | -22.6% |
| Q4 2015 | $389 | -28.9% | 321,535 | 0.0% | 0.03% | -32.6% |
| Q3 2015 | $547 | -18.2% | 321,535 | 0.0% | 0.05% | -8.0% |
| Q2 2015 | $669 | -23.7% | 321,535 | -0.6% | 0.05% | -21.9% |
| Q1 2015 | $877 | +8.8% | 323,535 | +3.2% | 0.06% | +4.9% |
| Q4 2014 | $806 | +30.0% | 313,535 | -7.4% | 0.06% | +17.3% |
| Q3 2014 | $620 | -31.9% | 338,535 | -0.7% | 0.05% | -31.6% |
| Q2 2014 | $911 | -23.2% | 341,035 | +0.7% | 0.08% | -26.9% |
| Q1 2014 | $1,186 | -21.3% | 338,735 | +0.5% | 0.10% | -23.5% |
| Q4 2013 | $1,507 | +33.8% | 337,085 | +21.5% | 0.14% | +24.8% |
| Q3 2013 | $1,126 | -2.4% | 277,460 | 0.0% | 0.11% | -9.2% |
| Q2 2013 | $1,154 | – | 277,460 | – | 0.12% | – |
Download | ||||||